SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-14-008097
Filing Date
2014-01-10
Accepted
2014-01-10 17:07:35
Documents
12

Document Format Files

Seq Description Document Type Size
1 FORM S-1 d652050ds1.htm S-1 1552426
2 EX-16.1 d652050dex161.htm EX-16.1 1886
3 EX-23.1 d652050dex231.htm EX-23.1 1274
4 EX-23.2 d652050dex232.htm EX-23.2 1984
11 GRAPHIC g652050g08r20.jpg GRAPHIC 97235
12 GRAPHIC g652050g88b19.jpg GRAPHIC 18996
  Complete submission text file 0001193125-14-008097.txt   6403907

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT itci-20130930.xml EX-101.INS 749036
6 XBRL TAXONOMY EXTENSION SCHEMA itci-20130930.xsd EX-101.SCH 41776
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20130930_cal.xml EX-101.CAL 60399
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20130930_def.xml EX-101.DEF 256641
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20130930_lab.xml EX-101.LAB 382056
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20130930_pre.xml EX-101.PRE 320928
Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-193313 | Film No.: 14522503
SIC: 2834 Pharmaceutical Preparations